Ranbaxy SWOT Analysis

Ranbaxy SWOT analysis evaluates the brand by its strengths, weaknesses, opportunities & threats. In SWOT Analysis of Ranbaxy, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

Ranbaxy is one of the leading brands in the pharma and healthcare sector. The article below lists the Ranbaxy SWOT and includes its target market, segmentation, positioning & USP.

SWOT Analysis of Ranbaxy

For Ranbaxy, SWOT analysis can help the brand focus on building upon its strengths and opportunities while addressing its weaknesses as well as threats to improve its market position.

Ranbaxy Strengths

The strengths of Ranbaxy looks at the key aspects of its business which gives it competitive advantage in the market. Some important factors in a brand's strengths include its financial position, experienced workforce, product uniqueness & intangible assets like brand value.

A list of strengths is mostly the starting point in starting SWOT analysis. Below are the Strengths in the SWOT Analysis of Ranbaxy :

1.Top 10 Global Generic Company with a spread over 125 countries

2. over 13,000 well trained Employees, over 50 nationalities

3. Strong presence in the International market with a major share and a strong presence in India as well

4.It has operations in nearly 50 countries and has 7 manufacturing plants

Ranbaxy Weaknesses

The weaknesses of a brand are certain aspects of its business which are it can improve to increase its position further. Certain weaknesses can be defined as attributes which the company is lacking or in which the competitors are better. Here are the weaknesses in the Ranbaxy SWOT Analysis:

1. It is heavily dependent upon generics for its revenue generation

2. Constantly regulated policies by the govt means operational efficiency is affected

Ranbaxy Opportunities

The opportunities for any brand can include areas of improvement to increase its business. A brand's opportunities can lie in geographic expansion, product improvements, better communication etc. Following are the opportunities in Ranbaxy SWOT Analysis:

1.increasing health awareness

2.Improvement in distribution network & brand building

3. They can leverage  Synriam, anti-malarial drug in brand building

Ranbaxy Threats

The threats for any business can be factors which can negatively impact its business. Some factors like increased competitor activity, changing government policies, alternate products or services etc. can be threats. The threats in the SWOT Analysis of Ranbaxy are as mentioned:

1.Increasingly stringent FDA Regulations

2.Exchange rate fluctuations

3.Global economic slowdown

Similar to Ranbaxy

1. Sun Pharma Industries
2. Dr.Reddy's

3. Lupin

4. GlaxoSmithKline Pharmaceuticals Ltd

Hence this concludes the Ranbaxy SWOT analysis.

Continue reading more about the brand/company.

About Ranbaxy

Ranbaxy Overview
Parent Company	Ranbaxy
Category	Pharmaceuticals
Sector	Pharma and Healthcare
Tagline/ Slogan	New boundaries, new Horizons; Trusted medicines healthier lives
USP	It is India’s largest pharmaceutical company
Ranbaxy STP
Segmentation	Anti-Infectives, Cardiovascular & Diabetes, Dermatological, Neuro-Psychiatry, Pain management, Gastro-Intestinal, Nutritional
Target Market	Healthcare professionals, wholesalers, generic distributors, and hospitals
Positioning	A diversifies global healthcare company focused on patient’s needs

This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Browse marketing analysis of more brands and companies similar to Ranbaxy. This section covers SWOT Analysis along with Segmentation, Target Market, Positioning & USP of more than 2000 brands from over 20 industry sectors.

Continue Reading: